In modern surgery, recovery is no longer measured only by whether the operation was technically successful. It is measured by how quickly a patient walks again, how much pain they carry home, how well tissues heal, and whether complications delay the return to normal life.
Increasingly, researchers are examining a nutrient that rarely gets headline attention in surgical conversations: vitamin D.
Long known for its role in bone health, vitamin D is now being studied for a broader recovery profile involving muscle function, immune response, wound repair, inflammation and pain sensitivity. The evidence is not yet strong enough to say that vitamin D supplementation guarantees better surgical outcomes. But the signal is becoming harder to ignore: patients who enter surgery with deficiency may face a tougher recovery road than those with adequate levels.
“Vitamin D is not a painkiller. But deficiency may weaken the body’s recovery environment — bone, muscle, immunity and tissue repair — at exactly the time surgery demands resilience.”
The basic biology is well established. The U.S. National Institutes of Health says vitamin D helps the body absorb calcium, supports muscles, enables nerves to carry signals, and helps the immune system fight bacteria and viruses. Deficiency in adults can cause osteomalacia, a condition associated with bone pain and muscle weakness.
That matters after surgery because pain recovery is not only about nerves and analgesics. It is also about inflammation, tissue healing, mobility, sleep, infection risk and confidence in movement. If muscles are weak, bones are fragile, tendons heal poorly, or inflammation stays high, pain can persist even after the surgical wound appears closed.
Recent orthopedic literature has strengthened this concern. A 2025 systematic review and meta-analysis in the Indian Journal of Orthopaedics examined shoulder procedures including rotator cuff repair and total shoulder arthroplasty. It found that vitamin D-deficient patients were about 1.2 times more likely to experience adverse events after these surgeries, including retear or revision-related outcomes. The authors concluded that physicians should consider preoperative vitamin D evaluation in patients undergoing shoulder surgeries, while also calling for more research.
The same review notes possible biological explanations: vitamin D deficiency has been linked with problematic wound healing, suboptimal tissue repair and infection risk. It also discusses tendon healing, collagen organization and inflammatory pathways as possible mechanisms through which deficiency may affect orthopedic recovery.
“The emerging surgical question is not whether vitamin D alone can heal a patient. It is whether deficiency removes one layer of biological support during a period when the body needs every advantage.”
Pain itself is also coming under investigation. Reviews on chronic post-surgical pain have reported that observational studies link vitamin D deficiency with higher rates of acute and chronic pain after surgery, although causality remains uncertain and more controlled trials are needed.
The caution is important. Vitamin D has seen cycles of overenthusiasm in wellness culture, with supplements sometimes marketed as a universal fix. The science is more disciplined than that. The 2024 Endocrine Society guideline updated its earlier recommendations and focused on vitamin D for prevention of disease in people without established indications for testing or treatment. It does not endorse indiscriminate screening for every healthy adult, but it does recognize specific risk groups where supplementation may be relevant.
For surgical patients, however, the conversation is different from casual supplementation. A patient preparing for orthopedic surgery, spine surgery, fracture repair, bariatric surgery, or a procedure involving bone and soft tissue healing may already be in a higher-risk context. In those cases, clinicians may reasonably evaluate vitamin D status as part of broader preoperative optimization.
India adds another dimension to the story. Despite abundant sunlight, vitamin D inadequacy remains widespread. A 2024 Scientific Reports study from South India found that 58% of its urban adult cohort was deficient and 23% insufficient. The authors also cited community-based Indian studies reporting deficiency prevalence between 50% and 94%, challenging the assumption that tropical sunlight automatically protects the population.
Urban indoor lifestyles, air-conditioned workdays, pollution, darker skin pigmentation, limited sun exposure, vegetarian dietary patterns, clothing habits and sunscreen use can all reduce vitamin D synthesis or intake. In other words, a country can be sunny while its population remains deficient.
The market is already reacting. Vitamin D testing and supplementation have become part of a larger global preventive-health and nutraceutical economy. Market estimates vary by publisher, but several 2025–2026 reports project continued growth in vitamin D testing and supplements, driven by aging populations, deficiency awareness and preventive health demand. One market analysis estimated the global vitamin D testing market at about US$1.2 billion in 2026, rising to US$2.0 billion by 2033.
But the clinical message should not be reduced to “take more vitamin D.” Too much vitamin D can be harmful. The NIH warns that excessive intake can cause high blood calcium, nausea, vomiting, weakness, confusion, dehydration, kidney stones and, in extreme cases, kidney failure or irregular heartbeat. Adults generally have an upper daily intake limit of 4,000 IU unless a healthcare provider prescribes a different therapeutic plan.
“The practical lesson is testing and correction, not blind supplementation. In surgery, precision matters.”
For patients, the safest takeaway is simple: before planned surgery, especially orthopedic or bone-related surgery, ask the doctor whether vitamin D testing is appropriate. If levels are low, correction should be done under medical guidance, with attention to dose, timing, calcium levels, kidney health, other medications and the urgency of surgery.
For hospitals and surgeons, vitamin D may become part of a wider prehabilitation checklist: nutrition, anemia correction, glucose control, smoking cessation, physical conditioning and mental readiness. Surgery is not a one-day event; it is a biological campaign that begins weeks before the operating room and continues months after discharge.
The evidence does not yet prove that vitamin D optimization will prevent chronic pain in every patient. It does suggest that deficiency is a modifiable risk factor worth respecting, particularly where pain recovery, muscle strength, wound healing and orthopedic outcomes are central.
In the next phase of surgical care, the question may shift from “Was the operation successful?” to “Was the patient biologically prepared to recover?”
